- Case Report
- Open Access
Multiple eccrine hidrocystomas on the upper lip: a case report
© Aneiros-Fernandez et al; licensee BioMed Central Ltd. 2009
Received: 11 November 2009
Accepted: 9 December 2009
Published: 9 December 2009
Multiple eccrine hidrocystomas of de upper lip are bening cystic lesions that are associated with a chronic course. It is reported in the literature as a rare pathology.
We describe the case of a 60-year-old woman who was referred to the dermatology department for presenting multiple lesions translucent papular asymptomic two years of evolution on the upper lip. Increase in size in summer and physical exercise, improving winter.
To make the diagnosis of multiple eccrine hidrocystomas is necessary clinical and histopathological findings, taking different lines of treatment.
Eccrine hidrocystomas are cystic tumor the sweat glands ducts, are relatively rare and account less than 1% of sumitted cutaneous biopsies . They are more frequent in fermales between 30 and 70 years of age and can occur as solitary or multiple cyst. Multiple eccrine hidrocystoma occur more frecuently around the eyes, cheeks, nose and less frecuently on the upper lip .
The eccrine hidrocystoma has been considered to be true ectatic eccrine ducts of the dermal portion. The occurrence of these injuries was caused by retention of sweat favored by increased temperature and physical exercise . There is an increased incidence in hyperthyroid patients, possibly related to hyperhidrosis. When the presentation is simply a cyst it may be mistaken with epidermal inclusión cyst, mucoid cyst and hidrocystoma apocrine. From the clinical point of view el eccrine hidrocystoma and apocrine hidrocystoma are difficult to distinguish; to be diagnosed histopathology is necessary. Apocrine hidrocystoma usually presented as multiple cysts and may have abundant papillary proyections into the cyst cavity or only have a simple apocrine type lining cell with large cytoplasm, PAS-positive diastase resistant granules, showing the beheading events of decapitation surrounded by myoepithelial cells . However the eccrine hidrocystomas are usually unilocular showing two layers of epitelial cuboidal without decapitation events or presence of myoepithelial cells. Have been described associated with Graves Basedow disease, Goltz-Gorlin and Schopf-Schulz-Passarge syndromes.
In regard of treatment, when are unique lesions performed surgical excision when are multiple lesions several treatments have been described with favorable response; tópica 1% atropine or scopolamine creams, with a 585 mm flashlamp-pupel pulse dye laser and botulim toxim [5, 6].
Eccrine hidrocystoma is not a serius injury but it is a mainly problem cosmetic.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- De Viragh PA, Szeimies RM, Eckert F: Apocrine cystoadenoma, apocrine hidrocystoma, and eccrine hidrocystoma: three distinct tumors defined by expression of keratins and human milk fat globulin 1. J Cutan Pathol. 1997, 24: 249-255. 10.1111/j.1600-0560.1997.tb01590.x.View ArticlePubMedGoogle Scholar
- Hashimoto K, Lever WF: Tumors of skin Appendages. Dermatology in General Medicine. Edited by: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF. 1987, McGraw-Hill, 773-793. 4Google Scholar
- Murayanna N, Tsuboi R, Unno K, Ogawa H: Multiple eccrine hidrocystomas. Br J Dermat. 1994, 131: 585-586. 10.1111/j.1365-2133.1994.tb08570.x.View ArticleGoogle Scholar
- Elder D, Elenitsas R, Jaworsky C, Johnson Lever's B: Histopathology of the skin. Edited by: Elder D, Elenitsas R, Jaworsky C, Johnson B. 1997, Philadelphia Lippincott-Raven, 770-8Google Scholar
- Armostrong DK, Walsh MY, Corbett JR: Multiple facial eccrine hidrocystomas: effective topical therapy with atropine. Br J Dermatolol. 1998, 139: 558-559. 10.1046/j.1365-2133.1998.02441.x.View ArticleGoogle Scholar
- Blugerman G, Schavelzon D, Dangelo S: Multiple eccrine hidrocystoma: a new therapeutic option with botulinum toxin. 2003, 29: 557-559.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.